Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma
NCT02400385Phase 2Withdrawn
- Sponsor
- California Pacific Medical Center Research Institute
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in melanoma, sponsored by California Pacific Medical Center Research Institute. Planned start Oct 2014; status: withdrawn.
02
Drugs
sunitinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02400385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02400385.